Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway

Exploring novel anticancer drugs to optimize the efficacy may provide a benefit for the treatment of colorectal cancer (CRC). Disulfiram (DSF), as an antialcoholism drug, is metabolized into diethyldithiocarbamate-copper complex (CuET) in vivo, which has been reported to exert the anticancer effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xin, Hou, Yichao, Weng, Xiaoling, Pang, Wenjing, Hou, Lidan, Liang, Yu, Wang, Yu, Du, Leilei, Wu, Tianqi, Yao, Mengfei, Wang, Jianhua, Meng, Xiangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794448/
https://www.ncbi.nlm.nih.gov/pubmed/33419984
http://dx.doi.org/10.1038/s41389-020-00295-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794448/
https://www.ncbi.nlm.nih.gov/pubmed/33419984
http://dx.doi.org/10.1038/s41389-020-00295-7

Ejemplares similares